Earnings To Be Announced Prior to Market
Open on Monday May 1st,
2023
TORONTO, April 19,
2023 /CNW/ - Think Research Corporation (TSXV: THNK)
("Think" or the "Company"), a company focused
on transforming healthcare through digital health software
solutions, announced today that it will release Fourth Quarter and
Full-Year 2022 Results pre-market, Monday,
May 1, 2023. Think's financial statements and Management
Discussion and Analysis will be available under the Company's
profile on SEDAR and on the Company's website as of 7:30 a.m. Eastern Time.
Subsequently, CEO Sachin Aggarwal
and CFO John Hayes with host a
conference call to discuss the results, with a Q&A session to
follow.
TIME: 8:30AM EST, Monday May 1st, 2023
Conference Call Participant Details:
To join the conference call without operator assistance, you may
register and enter your phone number HERE to receive an
instant automated call back.
Participants can also dial direct to be entered to the call by
an Operator:
Toronto: 416-764-8659
North American Toll Free: 1-888-664-6392
Webinar URL:
https://app.webinar.net/3Vv24ZxgO0d
About Think Research
Corporation
Think Research Corporation is an industry leader in delivering
knowledge-based digital health software solutions. The Company's
focused mission is to organize the world's health knowledge so
everyone gets the best care. Its evidence-based healthcare
technology solutions support the clinical decision-making process,
standardize care, to facilitate better health care outcomes. The
Company gathers, develops, and delivers knowledge-based solutions
globally to customers which typically includes enterprise clients,
hospitals, health regions, healthcare professionals, and / or
governments. The Company has gathered a significant amount of data
by building its repository of knowledge through its network and
group of companies, including acquired companies.
Think licenses its solutions to over 13,000 facilities for over
300,000 primary care, acute care, and long-term care doctors,
nurses and pharmacists that rely on the content and data provided
by Think to support their practices. Millions of patients and
residents annually receive better care due to the essential data
that Think produces, manages and delivers.
In addition, the Company collects and manages pharmaceutical and
clinical trial data via the BioPharma Services entity that Think
acquired on September 10, 2021.
BioPharma Services is a leading provider of bioequivalence and
Phase 1 clinical research services to pharmaceutical companies
globally. Think's other services include a network of digital-first
primary care clinics and medical clinics that provide elective
surgery. Visit: www.thinkresearch.com.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this news release.
For more
information: https://www.thinkresearch.com/ca/investors/
SOURCE Think Research Corporation